Safety
VetStem Regenerative Cells – Key Safety Factors:
- Autologous (from the patient back to the same patient): Tissue reaction risk is minimized
- Minimally manipulated: Cells are not differentiated or modified
- Accurate determination of each dose
- Quality assessment of each dose
- VetStem employs stringent processing protocols and quality control methods
- Hundreds of publications support the safety of autologous cell therapy in animals
- Reported canine adverse reaction rate is 0.1%
- Reported equine adverse reaction rate is 0.2%
- Reported feline adverse reaction rate is 0.3%
Pet owners should discuss appropriateness of treatment for their pet including potential complications of surgery, potential outcomes, a comprehensive treatment plan, and associated costs with their veterinarian prior to treatment. A checklist of points for dog and cat owners to consider can be found here.
